Wipro buys TTK's EVA and Good Home brands for Rs 2.56B
What's the deal? TTK Healthcare Ltd will sell its EVA personal care brand and Good Home home care brand to Wipro EnterprisesDealroom has a profile for this one. Try Dealroom → for Rs 256 crore (Rs 2.56 billion) plus GST. The Chennai-headquartered company's board approved the divestment on July 23, 2026. The sale transfers intellectual property, product formulations, and commercial inventory tied to both brands.
Why now? The two brands generated roughly Rs 148 crore in the 2025–26 financial year — about 17% of TTK Healthcare's Rs 857.28 crore operational turnover. The Rs 256 crore price values the assets at roughly 1.7 times their annual sales.
What's the endgame? TTK Healthcare wants to refocus on its core pharmaceutical, medical device, and healthcare manufacturing divisions. Management said the fresh liquidity will fund higher-margin segments including orthopedic implants, heart valve manufacturing, and specialised pharmaceuticals.
What changes for buyers? Consumer supply of EVA deodorants and Good Home air fresheners will continue uninterrupted through the transition. Distribution and retail contracts will fold into Wipro Consumer Care's logistics network over the second half of the fiscal year.
For Wipro, the deal expands its Wipro Consumer Care & Lighting arm, adding EVA and Good Home alongside brands such as Santoor, Yardley, and Chandrika. Wipro Enterprises Private Limited is an independent third party outside TTK Healthcare's promoter group, keeping the sale clear of related-party rules.
The transaction is slated for commercial closure by September 30, 2026, subject to customary statutory approvals.
The signal: The sale is a clean bet on focus over breadth. TTK Healthcare is shedding consumer-facing brands to double down on healthcare, while Wipro consolidates its grip on India's personal and home care shelves.
Read more: wownews24x7.com
Image credit: Generated with Gemini
